Contribution: Industrial Research Assistance Program – Contributions to Firms
Altum Pharmaceuticals Inc.
$430,500.00
Formulation development, bioavailability analysis, and assessment of AP-002 anti-osteoporosis activity in vivo
FY 2018-19 · 2019-01-01
Summary
This project will assess the anti-bone resorption activity of AP-002 in vivo in a rat osteoporosis model.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
765028691
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-01-01 | 2018-19 | $280,500.00 |
| 1 | 2019-01-01 | 2018-19 | $280,500.00 |
| 2 | 2019-01-01 | 2018-19 | $380,500.00 |
| 3 | 2019-01-01 | 2018-19 | $430,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 50,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 50 000 dollars.
Agreement End Date
2020-03-31
Agreement Number
919883
Agreement Start Date
2019-01-01
Agreement Title
Formulation development, bioavailability analysis, and assessment of AP-002 anti-osteoporosis activity in vivo
Agreement Title (French)
Développement de formulations, analyse de biodisponibilité et évaluation de l'activité anti-ostéoporose in vivo de l'AP-002
Agreement Type
Contribution
Agreement Value
$430,500.00
Amendment Date
2020-03-23
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will assess the anti-bone resorption activity of AP-002 in vivo in a rat osteoporosis model.
Description (French)
Ce projet évaluera l'activité antirésorption osseuse de l'AP-002 in vivo dans un modèle d'ostéoporose chez le rat.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver South
Federal Riding (French)
Vancouver-Sud
Federal Riding Number
59040
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
765028691
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Altum Pharmaceuticals Inc.
Recipient Postal Code
V6E 3P3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q4-919883
